Emerging human papillomavirus vaccines
نویسندگان
چکیده
منابع مشابه
Prophylactic human papillomavirus vaccines.
Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the second most common cause of death from cancer among women worldwide. This Review examines prophylactic HPV subunit vaccines based on the ability of the viral L1 capsid protein to form virus-like particles (VLPs) that induce high levels of neutralizing antibodies. Following preclinical research by laboratorie...
متن کاملVaccines against human papillomavirus.
Human papillomavirus has been identified as an etiological factor for cervical cancer, anogenital cancers and a subset of head and neck cancers. These important observations suggest that HPV vaccines have potential in the prevention and treatment of cervical cancer and other HPV-associated malignancies. The HPV genome encodes two HPV late genes, L1 and L2, which form the viral capsid. Early vir...
متن کاملThe human papillomavirus vaccines.
Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) among sexually active couples. Its annual incidence is approximately 5.5 million. Overall, an estimated 75% of sexually active men and women have been exposed to HPV at some point in their lives. HPV-16 and -18 account for about 70% of cancers of the cervix, vagina and anus, and for about 30%-40...
متن کاملHuman papillomavirus (HPV) vaccines
Kinoshita et al. 2014 48 patients (from same clinic as above and largely overlapping time period). 18 fulfilling the diagnostic criteria for CRPS-1. Abstract /Kinoshita et al, 2014 17 patients from an unknown time period. -Kinoshita et al, 2014 17 patients from an unknown time period. Letter to the editor / 2 adolescents Both patients fulfilled the fibromyalgia criteria and were 22 Richards et ...
متن کاملFostering acceptance of human papillomavirus vaccines.
Multivalent prophylactic human papillomavirus (HPV) vaccines currently in the late stages of clinical testing are safe, immunogenic, and efficacious; and phase 3 tests of a quadrivalent vaccine show that it is 100% effective at preventing HPV types 16 and 18-associated cervical intraepithelial neoplasia grades 2 and 3, adenocarcinoma in situ, and cervical cancer through 2 years of postvaccinati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Opinion on Emerging Drugs
سال: 2012
ISSN: 1472-8214,1744-7623
DOI: 10.1517/14728214.2012.744393